Newsroom

Industry News

4 Feb

CymaBay to Present at 17th Annual BIO CEO & Investor Conference

CymaBay Therapeutics Inc. (CBAY) announced today that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 17th Annual BIO CEO & Investor Conference on Monday, February 9 at 2:30 p.m. Eastern Time. The conference will take place at the Waldorf Astoria in...

Read more

4 Feb

Actinium Engages Dr. Roland Turck, Former President, Global Specialty Medicine, Bayer Healthcare as Board Advisor

Dr. Turck to Provide Strategic Advice to Actinium to Support Accelerated Development and Commercialization of Iomab-B Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it engaged Dr. Roland Turck, Managing...

Read more

3 Feb

Actinium to Present at the 17th Annual BIO CEO & Investor Conference

Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that a corporate overview will be presented at the 17thAnnual BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the...

Read more

2 Feb

BioSig Technologies Engages PCG Advisory as Agency of Record

BioSig Technologies(BSGM), a medical device company that is developing its proprietary PURE EP(TM) technology platform designed to improve the clinical outcomes of electrophysiology (EP) procedures, today announced it has retained PCG Advisory as its agency of record for capital markets advisory services, strategic and tactical digital and social media...

Read more

2 Feb

NephroGenex to Present at the 17th Annual BIO CEO & Investor Conference

NephroGenex, Inc. (NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault will present a corporate overview of the Company and meet with investors at the 17thAnnual BIO CEO & Investor Conference in New York City. The...

Read more

2 Feb

Soligenix Announces Presentation and Poster at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC

Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it will be presenting preclinical data from two biodefense programs at the upcoming American Society of Microbiology (ASM) Biodefense and...

Read more

2 Feb

Staffing 360 Solutions Releases Transcript of Earnings Call

Management Team Details the Financial Results for Fiscal Q2 2015 and Discusses the Company’s M&A Strategy Staffing 360 Solutions, Inc. (OTCQB: STAF), a public company executing a global buy-and-build strategy through the acquisition of staffing organizations with operations in the US and Europe, today announced the availability of the...

Read more

2 Feb

Celator® Pharmaceuticals to Present at BIO CEO and Investor Conference

Celator Pharmaceuticals, Inc. (CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced that Scott Jackson, Chief Executive Officer, will present an overview of the company at the BIO CEO and Investor Conference on Tuesday, February...

Read more

Page 234 of 276« First...102030...232233234235236...240250260...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address